Loading organizations...
Loading organizations...
Drug development company creating treatments for Sickle Cell Disease.
Modus Therapeutics has raised $27.4M across 5 funding rounds.
Modus Therapeutics has raised $27.4M in total across 5 funding rounds.
Modus Therapeutics has raised $27.4M in total across 5 funding rounds.
Modus Therapeutics's investors include Karolinska Development, Marten Steen, Viktor Drvota, Östersjöstiftelsen, Praktikerinvest, Rosetta Capital.
Modus Therapeutics has raised $27.4M across 5 funding rounds. Most recently, it raised $3.0M Other Equity in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 28, 2025 | $3.0M Other Equity | ||
| May 12, 2022 | $1.1M Other Equity | Karolinska Development | |
| Jul 15, 2021 | $3.5M Other Equity | ||
| Jul 13, 2018 | $15.8M Series A | Marten Steen | |
| Feb 21, 2017 | $4.0M Other Equity | Viktor Drvota, Östersjöstiftelsen, Praktikerinvest, Rosetta Capital |